Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Percentile
P14
Within normal range
vs 3Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-44.59%
2024-74.60%
202311.66%
2022219.04%
20210.00%
20200.00%
20190.00%
20180.00%